Concourse Financial Group Securities, Inc. Meridian Bioscience Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.52 Billion
  • Q1 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
N/A
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
N/A
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
N/A
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
N/A
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
N/A
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.0 - $33.97 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$31.15 - $33.39 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
SELL
$30.9 - $33.55 $3,738 - $4,059
-121 Closed
0 $0
Q2 2022

Aug 09, 2022
BUY
$23.75 - $31.69 $593 - $792
25 Added 26.04%
121 $4,000
Q2 2021

Aug 13, 2021
SELL
$18.01 - $28.32 $162 - $254
-9 Reduced 8.57%
96 $2,000
Q1 2021

May 13, 2021
BUY
$19.76 - $29.89 $2,074 - $3,138
105 New
105 $3,000
Q4 2020

Feb 02, 2021
BUY
$15.73 - $21.66 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$13.54 - $26.41 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$7.84 - $23.29 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$5.57 - $11.5 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.9 - $10.14 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$9.17 - $12.01 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$10.88 - $17.6 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$15.51 - $17.61 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$14.52 - $19.72 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$14.85 - $16.35 $0 - $0
0 New
0 $0

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email